L-carnitine consecutively administered to patients on hemodialysis improves beta-cell response

International Journal of Artificial Organs

Volumn 26, Issue 4, 2003, Pages 304-307

  Vazelov, Evgueniy ^a   Borissova, A M ^b   Kirilov, G ^b   Assenova, B ^a   Tchetirska, M ^a   Krivoshiev, S ^a  

^a UNIVERSITY HOSPITAL 'QUEEN GIOVANNA'   (Bulgaria)

^b UNIVERSITY HOSPITAL ALEXANDROVSKA   (Bulgaria)

Author keywords

Carbohydrate metabolism; Chronic renal failure (CRF); Hemodialysis treatment; L carnitine supplementation

Indexed keywords

DISEASES; HEMODIALYZERS; PATIENT TREATMENT;

BETA CELL; CARBOHYDRATE METABOLISM; CELL RESPONSE; CHRONIC RENAL FAILURE; END-STAGE RENAL DISEASE; HAEMODIALYSIS; HEMODIALYSIS TREATMENT; L-CARNITINE; L-CARNITINE SUPPLEMENTATION;

DIALYSIS;

BICARBONATE; C PEPTIDE; CARBOHYDRATE; CARNITINE; CELLULOSE ACETATE; GLUCOSE; INSULIN; POLYSULFONE; TOLBUTAMIDE;

ADULT; AREA UNDER THE CURVE; ARTICLE; CARBOHYDRATE METABOLISM; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET RESTRICTION; DRUG BLOOD LEVEL; DRUG EFFECT; FEMALE; GLUCOSE BLOOD LEVEL; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; HUMAN CELL; MALE; OXIDATION; PANCREAS ISLET BETA CELL; PROTEIN BLOOD LEVEL;

EID: 0038107436     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880302600405     Document Type: Article

References (16)

1. Vacha GM. Favourable effects of L-carnitine treatment on hypertriglyceridemia in hemodialysis patients. Am J Clin Nutr 1983; 38: 532-40.
2. Rebouche CJ, Engel AG. Kinetic compartmental analysis of carnitine metabolism in the human deficiency syndromes. J Clin Invest 1984; 73: 857-67.
3. Ebeling P, Tuominen JA, Arenas J, Garcia Benayas C, Koivisto VA. The association of acetyl-L-carnitine with glucose and lipid metabolism in human muscle in vivo: The effect of hyperinsulinemia. Metabolism 1997; 46: 1454-7.
4. Ferranini G. Interaction of carnitine with insulin-stimulated metabolism in humans. Am J Physiol 1988; 255: E946-52.
5. Gunal A, Celiker H, Donder E, Yesl S. The effect of L-carnitine on insulin resistance in hemodialysed patients with chronic renal failure. J Nephrol 1999; 12: 38-40.
6. Evans AM, Faull R, Fornasini G, Lemanowicz EF, Longo A, Pace S, Nation RL. Pharmacokinetics of L-carnitine in patients with end-stage renal disease undergoing long-term hemodialysis. Clin Pharmacol Ther 2000; 68: 238-49.
7. Boran M. Response to recombinant human erythropoietin (r-HuEpo) and L-carnitine combination in patients with anemia of end-stage renal disease. Nephron 1996; 73: 314-5.
8. Guarnieri G, Situlin R, Biolo G. Carnitine metabolism in uremia. Am J Kidney Dis 2001; 38 (suppl 1): S63-7.
9. Ahmad S. L-carnitine in dialysis patients. Semin Dial 2001; 14: 209-17.
10. Constantin-Teodosiu D, Young S, Wellock F, Short AH, Burden RP, Morgan AG, Greenhaff PL. Gender and age differences in plasma carnitine, muscle strength, and exercise tolerance in haemodialysis patients. Nephrol Dial Transplant 2002; 17: 1808-13.
11. Vesela E, Racek J, Trefil L, Jankovyich V, Pojer M. Effect of L-carnitine supplementation in hemodialysis patients. Nephron 2001; 88: 218-23.
12. Matsumoto Y, Sato M, Ohashi H, Araki H, Tadokoro M, Osumi Y, Ito H, Morita H, Amano I. Effects of L-carnitine supplementation on cardiac morbidity in hemodialyzed patients. Am J Nephrol 2000; 20: 201-7.
13. Romagnoli GF, Naso A, Carraro G, Lidestri V. Beneficial effects of L-carnitine in dialysis patients with impaired left ventricular function: An observational study. Curr Med Res Opin 2002; 18: 172-5.
14. Hurot JM, Cucherat M, Haugh M, Fouque D. Effects of L-carnitine supplementation in maintenance hemodialysis patients: A systematic review. J Am Soc Nephrol 2002; 13: 708-14.
15. Rabkin R, Ross BD, Mako ME. The handling of insulin, proinsulin and C-peptide by the isolated rat kidney. Diabetes 1978; 27 (suppl 1): S192-6.
16. Mak RHK, De Fronzo RA. Glucose and insulin metabolism in uremia. Nephron 1992; 61: 377-82.